The recent finding that SLC15A4 interacts with the adaptor protein TASL to recruit and activate IRF5 [21] provide essential insight towards developing inhibitors that can potentially block this interaction to modulate TLR7 signaling and SLE pathogenesis. Here, TASL is linked to systemic lupus erythematosus.